


Ask a doctor about a prescription for NEMEA 25 mg TABLETS
Package Leaflet: Information for the Patient
Nemea 25 mg tablets EFG
Clozapine
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Contents of the pack and further information
The active substance of Nemea is clozapine, which belongs to a group of medications called antipsychotics (also known as neuroleptics, used to treat specific mental disorders such as psychosis).
Clozapine is used to treat patients with schizophrenia when other medications have not worked. Schizophrenia is a mental illness that involves disorders of thought, emotional reactions, and behavioral disorders. You can only use this medication if you have already tried at least two other antipsychotic medications, including one of the new atypical antipsychotics for treating schizophrenia, and these medications have not responded or have caused severe side effects that cannot be treated.
Clozapine is also indicated for treating severe thought disorders, emotional reactions, and behavioral disorders that occur in Parkinson's disease, when other medications have not been effective.
Follow your doctor's instructions carefully.
Do not take Nemea
Tell your doctor and do not take Nemea if any of the above circumstances apply to you. Nemea should not be administered to anyone who is unconscious or in a coma.
Warnings and Precautions
The safety measures mentioned in this section are very important. You must comply with them to minimize the risk of severe side effects that can be life-threatening.
Before starting treatment with Nemea, tell your doctor if you have or have had any of the following circumstances:
Immediately before taking the next dose of Nemea tablets, inform your doctor if:
Medical Exams and Blood Tests
Before starting treatment with Nemea, your doctor will ask you about your medical history and perform a blood test to ensure that your white blood cell count is normal. It is essential to know this, as you need white blood cells to fight infections.
Make sure you have regular blood tests before, during, and after finishing treatment with Nemea.
Before starting treatment, your doctor will also perform a physical examination. Your doctor may perform an electrocardiogram (ECG) to check your heart, but only if it is necessary for you or if you have any special concerns.
If you have liver disorders, you will have periodic liver function tests throughout treatment with Nemea.
If you have high blood sugar levels (diabetes), your doctor may perform periodic checks of your blood sugar levels.
Nemea may alter your blood lipid levels. Nemea may cause weight gain. Your doctor may monitor your weight and lipid levels.
If you have a mild headache, dizziness, or weakness, or Nemea makes you feel this way, be careful when getting up from a sitting or lying position, as this can increase the risk of falls.
If you need to undergo surgery or if, for any reason, you cannot walk for a long period, discuss with your doctor that you are taking Nemea. You may be at risk of having a blood clot (thrombosis).
Children and Adolescents Under 16 Years
If you are under 16 years old, you should not take Nemea, as there is not enough information available for its use in this age group.
Use in Elderly Patients (60 Years and Older)
Patient over 60 years old may be more susceptible to the following side effects during treatment with Nemea: weakness or mild headache after changing position, dizziness, rapid heartbeat, urinary retention, and constipation.
Tell your doctor or pharmacist if you suffer from a disease called dementia.
Use of Nemea with Other Medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may take any other medication, including those obtained without a prescription or herbal treatments. You may need to take a different amount of your medications or different medications.
Do not take Nemea with other medications that prevent the proper functioning of the bone marrow and/or decrease the number of blood cells produced by the body, such as:
These medications increase your risk of developing agranulocitosis (deficit of white blood cells in the blood).
Taking Nemea at the same time as other medications may affect the proper action of Nemea and/or the other medications. Inform your doctor if you intend to take, are taking (even if treatment is about to finish), or have recently stopped taking any of the following medications:
This list is not complete. Your doctor and pharmacist have more information about medications that should be administered with caution or avoided while taking Nemea. They also know if the medications you are taking belong to any of the groups listed above. Discuss this with them.
Taking Nemea with Food and Drinks
During treatment with Nemea, do not drink alcohol.
Tell your doctor if you smoke and how often you consume beverages containing caffeine (coffee, tea, cola). Sudden changes in your smoking or caffeine consumption habits can also modify the effects of Nemea.
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. Your doctor will discuss the benefits and possible risks of using this medication during pregnancy with you. Inform your doctor immediately if you become pregnant during treatment with Nemea.
The following symptoms may appear in newborn babies of mothers who have used Nemea in the last trimester (the last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
Some women who take certain medications for mental illnesses have irregular or absent menstrual periods. If this has happened to you, your menstrual period will return to normal when your medication is replaced with Nemea. This means you should use effective contraceptives.
During treatment with Nemea, you should not breastfeed your baby. Clozapine, the active substance of Nemea, can pass into breast milk and affect the baby.
Driving and Using Machines
Nemea can cause fatigue, drowsiness, and seizures, especially at the start of treatment. Therefore, you should avoid driving or operating machinery while you have these symptoms.
Nemea can cause symptoms such as drowsiness, dizziness, or vision changes, and reduce your reaction ability. These effects, as well as the disease itself, can impair your ability to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention until your doctor assesses your response to this medication.
Nemea Contains Lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
To minimize the risk of experiencing epileptic seizures, drowsiness, or hypotension, it is necessary for your doctor to gradually increase the dose. Follow your doctor's administration instructions for this medication exactly. If in doubt, consult your doctor or pharmacist again. It is essential that you do not change the dose or stop taking Clozapine without first asking your doctor. Continue taking Clozapine for the time your doctor has indicated.
If you are a patient over 60 years old, your doctor may start treatment with a lower dose and increase it more gradually, as you may be more susceptible to developing some unexpected adverse reactions. (See section 2 "What you need to know before taking Nemea").
If you cannot achieve the prescribed dose with this tablet presentation, other presentations of this medication are available to achieve the prescribed dose.
Treatment of schizophrenia
Treatment is started with 12.5 mg (half a 25 mg tablet) once or twice on the first day, followed by 25 mg once or twice on the second day. Swallow the tablet with the help of a glass of water. If you tolerate it well, your doctor will gradually increase the dose in amounts of 25 or 50 mg over 2 to 3 weeks until you reach a dose of 300 mg per day. It may be necessary to continue increasing the dose in amounts of 50 or 100 mg twice a week, or preferably once a week.
The normal daily dose of clozapine is between 200 and 450 mg, divided into several doses per day. Some people may need higher doses. Doses of up to 900 mg per day are allowed. At daily doses above 450 mg, adverse reactions may increase (particularly seizures). Always take the minimum dose that is effective for you. Most patients should take part of the dose in the morning and another part at night. Your doctor will tell you exactly how to divide your daily dose. If your daily dose does not exceed 200 mg, you can take it as a single dose at night. Once the treatment with clozapine is working well for some time, your doctor will try treatment with lower doses. You will need to take clozapine for at least 6 months.
Treatment of severe thought disorders in patients with Parkinson's disease
The normal initial dose of clozapine is 12.5 mg (half a 25 mg tablet) at night. Swallow the tablet with the help of a glass of water. Your doctor will slowly increase the dose in amounts of 12.5 mg, with a maximum of two increases per week, until you reach a maximum dose of up to 50 mg at the end of the second week. Dose increments should be stopped or postponed if you feel weak, dizzy, or confused. To avoid such symptoms, your blood pressure will be measured during the first weeks of treatment.
The effective daily dose is between 25 and 37.5 mg, taken as a single dose at night. The dose can only be increased to more than 50 mg per day in exceptional cases. The maximum dose is 100 mg per day. Always take the minimum dose that is effective for you.
If you take more Nemea than you should
If you think you have taken more Nemea than you should, or if someone has taken some of your tablets, inform your doctor or pharmacist immediately or call the Toxicology Information Service. Telephone 91 562 04 20, indicating the medication and the amount taken.
The symptoms of overdose are:
Drowsiness, fatigue, lack of energy, unconsciousness, coma, confusion, hallucinations, agitation, incoherent speech, numbness in the limbs, tremors in the hands, seizures, increased saliva production, dilated pupils, blurred vision, low blood pressure, collapse, rapid or irregular heartbeat, shallow or difficult breathing.
If you forget to take Nemea
If you forget to take a dose, take the missed dose as soon as possible. If it is almost time for the next dose, do not take the missed dose and take the next dose at the scheduled time. Do not take a double dose to make up for the missed dose. If you have stopped taking clozapine for two or more days, do not start treatment again without consulting your doctor first.
If you interrupt treatment with Nemea
Do not interrupt treatment with clozapine without asking your doctor, as you may experience withdrawal symptoms. These symptoms include sweating, headache, nausea (feeling dizzy), vomiting (being dizzy), and diarrhea. If you experience any of these symptoms, consult your doctor immediately.These symptoms can be followed by more severe ones unless you are treated immediately.Your initial symptoms may recur. If you need to interrupt treatment, it is recommended to gradually decrease the dose in amounts of 12.5 mg over a period of 1 to 2 weeks.
Your doctor will give you instructions on how to reduce your daily dose. If you need to interrupt your treatment suddenly, your doctor should examine you.
If your doctor decides to restart treatment with clozapine and your last dose of clozapine was two days or more ago, you should start again with the initial dose of 12.5 mg.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Some side effects can be serious and require immediate medical attention.Tell your doctor immediately before taking the next Nemea tablet if you experience any of the following circumstances:
Very common(affect more than 1 in 10 patients):
Common(affect up to 1 in 10 patients):
Uncommon(affect up to 1 in 100 patients):
Rare(affect up to 1 in 1,000 patients):
Rare(affect up to 1 in 1,000 patients)or very rare(affect up to 1 in 10,000 patients):
Very rare(affect up to 1 in 10,000 patients):
Not known(frequency cannot be estimated from the available data):
During the use of Nemea, extremely intense and severe skin reactions, such as drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported. The adverse skin reaction may appear as a rash with or without blisters. There can be skin irritation, edema, and fever, and symptoms similar to those of the flu. The symptoms of DRESS syndrome usually appear approximately 2 to 6 weeks (possibly up to 8 weeks) after treatment begins.
If any of the above cases apply to you, inform your doctor immediately before taking the next Nemea tablet.
Other side effects:
Very common(affect more than 1 in 10 patients):
Drowsiness, dizziness, increased saliva production.
Common(affect up to 1 in 10 patients):
High levels of white blood cells in the blood (leukocytosis), high levels of a certain type of white blood cells in the blood (eosinophilia), weight gain, blurred vision, headache, tremors, stiffness, restlessness, agitation, seizures, sudden movements, abnormal movements, inability to initiate movement, inability to remain still, changes in the heart's electrocardiogram (ECG) test, high blood pressure, weakness or mild headache after changing position, nausea (feeling dizzy), vomiting (being dizzy), loss of appetite, dry mouth, minor anomalies in liver function tests, loss of bladder control, difficulty urinating, fatigue, fever, increased sweating, elevated body temperature, speech disorders (e.g., slurred words).
Uncommon(affect up to 1 in 100 patients):
Deficit of white blood cells in the blood (agranulocytosis), speech disorder (e.g., stuttering).
Rare(affect up to 1 in 1,000 patients):
High levels of red blood cells in the blood (anemia), restlessness, agitation, confusion, delirium, irregular heartbeat, inflammation of the heart muscle (myocarditis) or the membrane surrounding the heart muscle (pericarditis), accumulation of fluid around the heart (pericardial effusion), high blood sugar levels, diabetes mellitus, blood clotting in the lungs (pulmonary thromboembolism), liver inflammation (hepatitis), liver disease that causes yellowing of the skin/dark urine/itching, elevated levels in the blood of an enzyme called creatine phosphokinase.
Very rare(affect up to 1 in 10,000 patients):
Increased number of blood platelets with possible blood vessel clotting, uncontrolled movements of the mouth/tongue and lips, obsessive thoughts and repetitive compulsive behaviors (obsessive-compulsive symptoms), skin reactions, swelling of the face (due to inflammation of the salivary glands), difficulty breathing, very high levels of triglycerides or cholesterol in the blood, heart muscle disease (cardiomyopathy), cardiac arrest (cardiac arrest), sudden unexpected death.
Not known(frequency cannot be estimated from the available data):
Changes in brain wave recordings (electroencephalogram/EEG), diarrhea, stomach discomfort, heartburn, stomach discomfort after eating, muscle weakness, muscle spasms, muscle pain, nasal congestion, nocturnal enuresis, sudden and uncontrollable increase in blood pressure (pseudopheochromocytoma), involuntary contraction that causes the body to curve to one side (pleurotonos), if you are a man, ejaculation disorder, in which semen enters the bladder instead of ejaculating through the penis (dry orgasm or retrograde ejaculation), rash, purple spots, fever or itching due to blood vessel inflammation, colon inflammation that causes diarrhea, abdominal pain, fever, skin color change, butterfly-shaped rash on the face, joint pain, muscle pain, fever, and fatigue (lupus erythematosus), restless legs syndrome (irresistible urge to move the legs or arms, usually accompanied by uncomfortable sensations during rest periods, especially in the afternoon or evening, and which is temporarily relieved by movement).
In elderly patients with dementia, a small increase in the number of deaths has been reported in patients taking antipsychotics compared to those who do not take them.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines, website: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack and carton. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30 ºC.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point of the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Nemea
Appearance of the Product and Package Contents
Nemea 25 mg tablets are yellow, round, scored, and marked with "CPN 25" on one side. Each tablet contains 25 mg of clozapine.
They are presented in perforated unit-dose blisters contained in cartons of 40x1 tablets.
Marketing Authorization Holder and Manufacturer
Holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 – 2ª planta
28023 Aravaca – Madrid, Spain
Phone: +34 91 357 11 25
Fax: +34 91 307 09 70
e-mail: [email protected]
Manufacturers
Synthon BV
Microweg 22
6545 CM Nijmegen, Netherlands
or
Synthon Hispania, S.L.
Castello, 1, Polígono ”Las Salinas”
08830 Sant Boi de Llobregat (Barcelona), Spain
or
G.L.PHARMA GMBH
Schlossplatz 1
Lannach 8502, Austria
This medicine is authorized in the member states of the European Economic Area under the following names:
Austria: Lanolept 25/50/100 mg – tablets
Italy: Clozapine Chiesi 25/50/100 mg
Portugal: Clozapine Generis 25/100 mg tablets
Netherlands: Clozapine 25/50/100 mg, tablets
Spain: Nemea 25/100 mg tablets
Iceland: Clozapin Medical 25/100 mg tablets
Date of the last revision of this prospectus: March 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of NEMEA 25 mg TABLETS in October, 2025 is around 3.54 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for NEMEA 25 mg TABLETS – subject to medical assessment and local rules.